These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11199943)

  • 1. Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications.
    Wassef AA; Hafiz NG; Hampton D; Molloy M
    J Clin Psychopharmacol; 2001 Feb; 21(1):21-6. PubMed ID: 11199943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia.
    Wassef AA; Dott SG; Harris A; Brown A; O'Boyle M; Meyer WJ; Rose RM
    J Clin Psychopharmacol; 2000 Jun; 20(3):357-61. PubMed ID: 10831024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar ataxia with intravenous valproate and haloperidol.
    Ranjan S; Jagadheesan K; Nizamie SH
    Aust N Z J Psychiatry; 2002 Apr; 36(2):268. PubMed ID: 11982555
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
    Casey DE; Daniel DG; Wassef AA; Tracy KA; Wozniak P; Sommerville KW
    Neuropsychopharmacology; 2003 Jan; 28(1):182-92. PubMed ID: 12496955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive.
    Glick ID; Bosch J; Casey DE
    J Clin Psychopharmacol; 2009 Jun; 29(3):267-71. PubMed ID: 19440081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
    Sekhar S; Kalra B; Mendhekar DN; Tekur U
    J Clin Pharmacol; 2010 Jun; 50(6):688-92. PubMed ID: 20075184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia.
    Suzuki T; Uchida H; Takeuchi H; Nakajima S; Nomura K; Tanabe A; Yagi G; Watanabe K; Kashima H
    Hum Psychopharmacol; 2009 Dec; 24(8):628-38. PubMed ID: 19946935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
    McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
    J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
    Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L
    Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.
    Hamilton SH; Revicki DA; Edgell ET; Genduso LA; Tollefson G
    Pharmacoeconomics; 1999 May; 15(5):469-80. PubMed ID: 10537964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia.
    Larrison AL; Babin SL; Xing Y; Patel SS; Wassef AA; Sereno AB
    Hum Psychopharmacol; 2011 Oct; 26(7):517-25. PubMed ID: 22031266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis Study.
    Tseng PT; Chen YW; Chung W; Tu KY; Wang HY; Wu CK; Lin PY
    Medicine (Baltimore); 2016 Jan; 95(4):e2475. PubMed ID: 26825886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.
    Zhu B; Tunis SL; Zhao Z; Baker RW; Lage MJ; Shi L; Tohen M
    Curr Med Res Opin; 2005 Apr; 21(4):555-64. PubMed ID: 15899104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
    Müller-Oerlinghausen B; Retzow A; Henn FA; Giedke H; Walden J
    J Clin Psychopharmacol; 2000 Apr; 20(2):195-203. PubMed ID: 10770458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
    Gau SS; Chung CH; Gau CS
    J Clin Psychopharmacol; 2008 Jun; 28(3):271-8. PubMed ID: 18480683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N; Foster RH; Olney R; Plosker GL
    Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.